Pumarix Union européenne - anglais - EMA (European Medicines Agency)

pumarix

glaxosmithkline biologicals s.a.  - pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted)  - influenza, human; immunization; disease outbreaks - vaccines - prophylaxis of influenza in an officially declared pandemic situation.pandemic-influenza vaccine should be used in accordance with official guidance.

INACTIVATED INFLUENZA VACCINE (SPLIT VIRION) BP, suspension for injection in prefilled syringe.Influenza vaccine (split virion, Irlande - anglais - HPRA (Health Products Regulatory Authority)

inactivated influenza vaccine (split virion) bp, suspension for injection in prefilled syringe.influenza vaccine (split virion,

sanofi pasteur - a/michigan/45/2015 (h1n1)pdm09 - like strain (a/michigan/45/2015, nymc x-275); a/hong kong/4801/2014 (h3n2) - like strain (a/hong kong/4801/2014, nymc x-263b); b/brisbane/60/2008 - like strain (b/brisbane/60/2008) - suspension for injection - 15/15/15mc percent volume/volume - influenza vaccines; influenza, inactivated, split virus or surface antigen

FLUARIX TETRA inactivated split influenza vaccine suspension for injection 0.5 mL pre-filled PRTC syringe without needle, SH2024 influenza season Australie - anglais - Department of Health (Therapeutic Goods Administration)

fluarix tetra inactivated split influenza vaccine suspension for injection 0.5 ml pre-filled prtc syringe without needle, sh2024 influenza season

glaxosmithkline australia pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: dl-alpha-tocopheryl acid succinate; potassium chloride; sodium chloride; water for injections; polysorbate 80; dibasic sodium phosphate dodecahydrate; magnesium chloride hexahydrate; octoxinol 10; monobasic potassium phosphate - fluarix tetra is a quadrivalent vaccine indicated for active immunisation of adults and children from 6 months of age for the prevention of influenza disease caused by the influenza virus types a and b contained in the vaccine (see section 5.1 pharmacodynamic properties, clinical trials).,the use of fluarix tetra should be based on official recommendations.

FLUARIX TETRA inactivated split influenza vaccine suspension for injection 0.5 mL pre-filled syringe without needle, SH2024 influenza season Australie - anglais - Department of Health (Therapeutic Goods Administration)

fluarix tetra inactivated split influenza vaccine suspension for injection 0.5 ml pre-filled syringe without needle, sh2024 influenza season

glaxosmithkline australia pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: dl-alpha-tocopheryl acid succinate; potassium chloride; sodium chloride; water for injections; polysorbate 80; dibasic sodium phosphate dodecahydrate; magnesium chloride hexahydrate; octoxinol 10; monobasic potassium phosphate - fluarix tetra is a quadrivalent vaccine indicated for active immunisation of adults and children from 6 months of age for the prevention of influenza disease caused by the influenza virus types a and b contained in the vaccine (see section 5.1 pharmacodynamic properties, clinical trials).,the use of fluarix tetra should be based on official recommendations.

Foclivia Union européenne - anglais - EMA (European Medicines Agency)

foclivia

seqirus s.r.l.  - influenza virus surface antigens, inactivated: a/viet nam/1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - influenza vaccines - prophylaxis of influenza in an officially declared pandemic situation.pandemic influenza vaccine should be used in accordance with official guidance.

Quadrivalent Influenza Vaccine (split virion, inactivated), suspension for injection in pre-filled syringe Quadrivalent influenza vaccine (split virion, inactivated) Irlande - anglais - HPRA (Health Products Regulatory Authority)

quadrivalent influenza vaccine (split virion, inactivated), suspension for injection in pre-filled syringe quadrivalent influenza vaccine (split virion, inactivated)

sanofi pasteur - a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238; a/darwin/9/2021 (h3n2) - like strain (a/darwin/9/2021, ivr-228); b/austria/1359417/2021 - like strain (b/michigan/01/2021, wild type); b/phuket/3073/2013 -like strain (b/phuket/3073/2013, wild type) - suspension for injection in pre-filled syringe - 15 microgram(s) - influenza vaccines; influenza, inactivated, split virus or surface antigen

Fluarix Tetra suspension for injection in pre-filled syringe Influenza vaccine (split virion, inactivated) Irlande - anglais - HPRA (Health Products Regulatory Authority)

fluarix tetra suspension for injection in pre-filled syringe influenza vaccine (split virion, inactivated)

glaxosmithkline (ireland) limited - a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238; a/darwin/9/2021 (h3n2)-like strain (a/darwin/6/2021, ivr-227); b/austria/1359417/2021 - like strain (b/austria/1359417/2021, bvr-26) [victoria lineage]; b/phuket/3073/2013 -like strain (b/phuket/3073/2013, wild type) - suspension for injection in pre-filled syringe - 15 international unit(s) - influenza vaccines; influenza, inactivated, split virus or surface antigen